NOS2 and obesity disorder: The genetic disruption of iNOS expression protects against obesity-associated insulin resistance, suggesting that iNOS causes insulin resistance through NO-mediated tyrosine phosphorylation of key proteins involved in insulin signaling, promoting an impairment of glucose transport in liver and skeletal muscle [68,70].